CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Jiangsu Hengrui Medicine Co Ltd Company Snapshot
Jiangsu Hengrui Medicine Co Ltd operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Jiangsu Hengrui Medicine Co Ltd with three other companies in this sector in China: Humanwell Healthcare Group Co Ltd (2017 sales of 15.45 billion Chinese Renmimbi [US$2.46 billion] ), Harbin Pharmaceutical Group Company Limited (12.02 billion Chinese Renmimbi [US$1.92 billion] of which 66% was Medicine Trade), and Beijing Tongrentang Co., Ltd. (13.36 billion Chinese Renmimbi [US$2.13 billion] of which 52% was Retail Operation).

Sales Analysis. During the year ended December of 2017, sales at Jiangsu Hengrui Medicine Co Ltd were 13.84 billion Chinese Renmimbi (US$2.21 billion). This is an increase of 24.7% versus 2016, when the company's sales were 11.09 billion Chinese Renmimbi. This was the fifth consecutive year of sales increases at Jiangsu Hengrui Medicine Co Ltd (and since 2012, sales have increased a total of 155%). Sales of Medicinal Manufacturing saw an increase of 24.8% in 2017, from 11.08 billion Chinese Renmimbi to 13.82 billion Chinese Renmimbi. Not all segments of Jiangsu Hengrui Medicine Co Ltd experienced an increase in sales in 2017: sales of Other Businesses fell 35.0% to 11.56 million Chinese Renmimbi. (However, this segment's sales were only a very small portion of the company's overall sales).
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Jiangsu Hengrui Medicine Co Ltd
  Stock Performance Chart for Jiangsu Hengrui Medicine Co Ltd
 
  Stock Data: Recent Stock Performance:
  Current Price (4/20/2018): 84.03
(Figures in Chinese Renmimbi)
1 Week 3.6%   13 Weeks -0.7%  
4 Weeks 13.0%   52 Weeks 79.2%  
 
Jiangsu Hengrui Medicine Co Ltd Key Data:
  Ticker: 600276 Country: China
  Exchanges: SHG Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2017 Sales 13,835,629,370
(Year Ending Jan 2018).
Employees: 14,864
  Currency: Chinese Renmimbi Market Cap: 236,316,260,821
  Fiscal Yr Ends: December Shares Outstanding: 2,812,284,432
  Share Type: A Gu Closely Held Shares: 1,597,071,821
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.